Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the Abbott FlexNav™ Delivery System for Portico Transcatheter Aortic Valve Implantation in High and Extreme Risk Patients With Symptomatic Severe Aortic Stenosis

NCT03724812 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT03724812
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03724812 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the Abbott FlexNav™ Delivery System for Portico Transcatheter Aortic Valve Implantation in High and Extreme Risk Patients With Symptomatic Severe Aortic Stenosis
Lead sponsor
Abbott Medical Devices
Phase
Not applicable
Overall status
Completed
Start date
February 26, 2019
Completion date
February 10, 2021
Enrollment
46 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

symptomatic severe aortic stenosis